Paula
Rodríguez Otero
Consultora Médica
Karolinska University Hospital
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska University Hospital (3)
2021
-
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design
Future Oncology, Vol. 17, Núm. 16, pp. 1987-2003
2017
-
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study
Leukemia, Vol. 31, Núm. 11, pp. 2443-2448
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557